SARAH HALLEY: Open Payments
NPI 1437512191 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,420 in 74 payments from 18 companies in 2025. Trend: 2023 $1,255 · 2024 $1,136 · 2025 $1,420
Food & beverage: $1,321Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $321 |
| ABBVIE INC. | 13 | $221 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $145 |
| Ardelyx, Inc. | 7 | $135 |
| Regeneron Healthcare Solutions, Inc. | 5 | $128 |
| GENZYME CORPORATION | 4 | $115 |
| QOL Medical, LLC | 4 | $67 |
| Celltrion USA Inc. | 2 | $37 |
| PFIZER INC. | 2 | $33 |
| Lilly USA, LLC | 2 | $33 |
Products named: TREMFYA, DUPIXENT, IBSRELA, ENTYVIO, RINVOQ, CREON, Sucraid, MAVYRET.
Industry payments across SC — which companies pay providers there.
